Nature's Miracle Holding Inc. Files S-1/A Amendment
Ticker: NMHIW · Form: S-1/A · Filed: Jul 22, 2024 · CIK: 1947861
Sentiment: neutral
Topics: ipo, sec-filing, amendment
TL;DR
Nature's Miracle Holding Inc. (fka LBBB Merger Corp.) filed an S-1/A amendment on 7/22/24. IPO incoming?
AI Summary
Nature's Miracle Holding Inc. filed an S-1/A amendment on July 22, 2024, for its registration statement. The company, formerly LBBB Merger Corp., is incorporated in Delaware and operates in the farm machinery & equipment sector. Its principal executive offices are located at 3281 E. Guasti Road, Suite 175, Ontario, CA 91761.
Why It Matters
This filing indicates Nature's Miracle Holding Inc. is moving forward with its public offering process, which could lead to increased liquidity and capital for the company.
Risk Assessment
Risk Level: medium — As an S-1/A filing, it signifies a company pursuing an IPO, which inherently carries market and execution risks.
Key Numbers
- 333-280066 — Registration Number (Identifies the specific registration for this filing.)
- 0001947861 — Central Index Key (Unique identifier for the filer.)
Key Players & Entities
- Nature's Miracle Holding Inc. (company) — Registrant
- LBBB Merger Corp. (company) — Former company name
- 333-280066 (dollar_amount) — SEC Registration Number
- July 22, 2024 (date) — Filing date
- Tie (James) Li (person) — Chief Executive Officer
FAQ
What is the purpose of this S-1/A filing?
This is Amendment No. 2 to Form S-1, indicating updates or revisions to the initial registration statement filed with the SEC.
When was this amendment filed?
The amendment was filed on July 22, 2024.
What was the company's former name?
The company was formerly known as LBBB Merger Corp.
Where is Nature's Miracle Holding Inc. headquartered?
The company's principal executive offices are located at 3281 E. Guasti Road, Suite 175, Ontario, CA 91761.
What is the company's primary industry?
The company is classified under FARM MACHINERY & EQUIPMENT [3523].
Filing Stats: 4,554 words · 18 min read · ~15 pages · Grade level 14.8 · Accepted 2024-07-19 19:18:18
Key Financial Figures
- $0.0001 — ) one share of common stock, par value, $0.0001 per share ("Common Stock"); and (ii) on
- $0.4062 — is exercisable at an exercise price of $0.4062 per share (100% of the assumed offering
- $0 — d to the public in this offering, minus $0.0001, and the exercise price of each Pr
- $230,000,000 m — regate value of which was equal to: (a) $230,000,000 minus (b) the estimated Closing Net Indeb
- $8.9 million — 023 generated revenues of approximately $8.9 million and incurred a gross loss of approximat
- $0.9 million — incurred a gross loss of approximately $0.9 million as compared to revenues of approximatel
- $18.6 million — s compared to revenues of approximately $18.6 million and a gross profit of $1.7 million in t
- $1.7 million — ely $18.6 million and a gross profit of $1.7 million in the fiscal year ended December 31, 2
- $2.2 million — 024 generated revenues of approximately $2.2 million and incurred a gross profit of approxim
- $312,317 — ncurred a gross profit of approximately $312,317 as compared to revenues of approximatel
- $3.0 million — s compared to revenues of approximately $3.0 million and a gross profit of $297,260 in the p
- $297,260 — tely $3.0 million and a gross profit of $297,260 in the period ended March 31, 2023. CE
- $10 million — of additional facilities may cost up to $10 million each, consisting of, among other things
- $180,000 — placement (the "July 2024 Offering"), a $180,000 convertible note (the "July 2024 Note"
- $27,500 — es") with an original issue discount of $27,500 and a warrant (the "July 2024 Warrant")
Filing Documents
- ea0209691-s1a2_natures.htm (S-1/A) — 2509KB
- ea020969101ex23-1_natures.htm (EX-23.1) — 3KB
- ea020969101ex-fee_natures.htm (EX-FILING FEES) — 48KB
- image_001.jpg (GRAPHIC) — 17KB
- image_002.jpg (GRAPHIC) — 2KB
- image_003.jpg (GRAPHIC) — 2KB
- image_004.jpg (GRAPHIC) — 3KB
- image_005.jpg (GRAPHIC) — 2KB
- image_006.jpg (GRAPHIC) — 2KB
- image_007.jpg (GRAPHIC) — 1KB
- image_008.jpg (GRAPHIC) — 2KB
- image_009.jpg (GRAPHIC) — 2KB
- image_010.jpg (GRAPHIC) — 3KB
- image_011.jpg (GRAPHIC) — 3KB
- image_012.jpg (GRAPHIC) — 4KB
- image_013.jpg (GRAPHIC) — 4KB
- image_014.jpg (GRAPHIC) — 2KB
- image_015.jpg (GRAPHIC) — 4KB
- fin_001.jpg (GRAPHIC) — 8KB
- fin_002.jpg (GRAPHIC) — 5KB
- ex23-1_001.jpg (GRAPHIC) — 31KB
- ex23-1_002.jpg (GRAPHIC) — 14KB
- 0001213900-24-063182.txt ( ) — 12160KB
- nmhi-20240331.xsd (EX-101.SCH) — 120KB
- nmhi-20240331_cal.xml (EX-101.CAL) — 67KB
- nmhi-20240331_def.xml (EX-101.DEF) — 523KB
- nmhi-20240331_lab.xml (EX-101.LAB) — 850KB
- nmhi-20240331_pre.xml (EX-101.PRE) — 534KB
- ea0209691-s1a2_natures_htm.xml (XML) — 1500KB
RISK FACTORS
RISK FACTORS 11 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS 29
USE OF PROCEEDS
USE OF PROCEEDS 29 MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS 29 DIVIDEND POLICY 30 CAPITALIZATION 30
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 32
BUSINESS
BUSINESS 45 MANAGEMENT 64
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 70 PRINCIPAL STOCKHOLDERS 74 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 76
DESCRIPTION OF SECURITIES
DESCRIPTION OF SECURITIES 80
UNDERWRITING
UNDERWRITING 87 EXPERTS 89 LEGAL MATTERS 90 WHERE YOU CAN FIND MORE INFORMATION 90 INDEX TO FINANCIAL STATEMENTS F-1 You should rely only on the information contained in this prospectus or any prospectus supplement or amendment. Neither we, nor the underwriters, have authorized any other person to provide you with information that is different from, or adds to, that contained in this prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. Neither we nor the underwriters take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. You should assume that the information contained in this prospectus or any free writing prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our securities. Our business, financial condition, results of operations and prospects may have changed since that date. We are not making an offer of any securities in any jurisdiction in which such offer is unlawful. No action is being taken in any jurisdiction outside the United States to permit a public offering of our securities or possession or distribution of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this public offering and the distribution of this prospectus applicable to that jurisdiction. i ABOUT THIS PROSPECTUS Throughout this prospectus, unless otherwise designated or the context suggests otherwise, all references to the "Company," "Nature's Miracle," the "registrant," "we," "our" or "us" in this prospectus mean Nature's Miracle Holding Inc., a Delaware corporation, and its subsidiaries; "year" or "fiscal year" means the year ending December 31st; all dollar or $ references, when used in this prospe